RA Capital Management Reports Sale of $9.13 Million in Lenz Therapeutics Shares
RA Capital Management reported selling $9.13 million in Lenz Therapeutics common shares.
RA Capital Management reported selling $9.13 million in Lenz Therapeutics common shares.